172 related articles for article (PubMed ID: 21080762)
1. Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention.
Krag A; Pedersen EB; Møller S; Bendtsen F
Scand J Clin Lab Invest; 2011 Apr; 71(2):112-6. PubMed ID: 21080762
[TBL] [Abstract][Full Text] [Related]
2. Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects.
Krag A; Bendtsen F; Pedersen EB; Holstein-Rathlou NH; Møller S
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1295-300. PubMed ID: 18753292
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
Graffe CC; Bech JN; Lauridsen TG; Pedersen EB
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F917-27. PubMed ID: 22262484
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin V2 receptors, ENaC, and sodium reabsorption: a risk factor for hypertension?
Bankir L; Bichet DG; Bouby N
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F917-28. PubMed ID: 20826569
[TBL] [Abstract][Full Text] [Related]
5. Effects of terlipressin on water excretion after oral water load test in nonazotemic cirrhotic patients with ascites without hyponatremia.
Kalambokis GN; Pappas K; Baltayiannis G; Katsanou A; Tsianos EV
Scand J Gastroenterol; 2010 Dec; 45(12):1509-15. PubMed ID: 20695722
[TBL] [Abstract][Full Text] [Related]
6. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
[TBL] [Abstract][Full Text] [Related]
7. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
Colson PH; Virsolvy A; Gaudard P; Charrabi A; Corbani M; Manière MJ; Richard S; Guillon G
Pharmacol Res; 2016 Nov; 113(Pt A):257-264. PubMed ID: 27586252
[TBL] [Abstract][Full Text] [Related]
8. Chronic activation of vasopressin-2 receptors induces hypertension in Liddle mice by promoting Na
Stockand JD; Mironova EV; Xiang H; Soares AG; Contreras J; McCormick JA; Gurley SB; Pao AC
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F468-F478. PubMed ID: 35900342
[TBL] [Abstract][Full Text] [Related]
9. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.
Krag A; Møller S; Henriksen JH; Holstein-Rathlou NH; Larsen FS; Bendtsen F
Hepatology; 2007 Dec; 46(6):1863-71. PubMed ID: 18027874
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans.
Bankir L; Fernandes S; Bardoux P; Bouby N; Bichet DG
J Am Soc Nephrol; 2005 Jul; 16(7):1920-8. PubMed ID: 15888562
[TBL] [Abstract][Full Text] [Related]
11. Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney.
Lauridsen TG; Vase H; Bech JN; Nielsen S; Pedersen EB
Eur J Endocrinol; 2010 May; 162(5):961-9. PubMed ID: 20203161
[TBL] [Abstract][Full Text] [Related]
12. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
Decaux G
J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
[TBL] [Abstract][Full Text] [Related]
13. Effects of dihydralazine on renal water and aquaporin-2 excretion in humans.
Vase H; Lauridsen TG; Bech JN; Pedersen EB
Scand J Clin Lab Invest; 2009; 69(1):45-51. PubMed ID: 18728933
[TBL] [Abstract][Full Text] [Related]
14. Terlipressin resolves ascites of cirrhotic rats through downregulation of aquaporin 2.
Huang YY; Sun JY; Wang JY; Bai CX; He BM
J Int Med Res; 2012; 40(5):1735-44. PubMed ID: 23206455
[TBL] [Abstract][Full Text] [Related]
15. Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension.
Graffe CC; Bech JN; Lauridsen TG; Vase H; Pedersen EB
BMC Nephrol; 2012 Mar; 13():15. PubMed ID: 22452789
[TBL] [Abstract][Full Text] [Related]
16. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
17. Protein-enriched diet increases water absorption via the aquaporin-2 water channels in healthy humans.
Lauridsen TG; Vase H; Starklint J; Bech JN; Pedersen EB
Nephrol Dial Transplant; 2010 Aug; 25(8):2502-10. PubMed ID: 20237060
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608
[TBL] [Abstract][Full Text] [Related]
19. Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans.
Matthesen SK; Larsen T; Vase H; Lauridsen TG; Pedersen EB
Scand J Clin Lab Invest; 2012 Feb; 72(1):78-86. PubMed ID: 22149452
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells.
Aoyagi T; Izumi Y; Hiroyama M; Matsuzaki T; Yasuoka Y; Sanbe A; Miyazaki H; Fujiwara Y; Nakayama Y; Kohda Y; Yamauchi J; Inoue T; Kawahara K; Saito H; Tomita K; Nonoguchi H; Tanoue A
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F100-7. PubMed ID: 18448596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
